Brief: Eloxx Pharmaceuticals Inc- Entered Into A Sales Agreement With Oppenheimer & Co. Inc
24/05/2023 13:40
May 24 (Reuters) - Eloxx Pharmaceuticals Inc ELOX.O :
* ELOXX PHARMACEUTICALS INC- ENTERED INTO A SALES AGREEMENT
WITH
OPPENHEIMER & CO. INC.
* ELOXX PHARMACEUTICALS INC- UNDER DEAL, MAY OFFER AND SELL
SHARES
OF ITS COMMON STOCK FOR UP TO $50.0 MILLION
Source text for Eikon: [http://bitly.ws/FmNM]
Further company coverage: ELOX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Eloxx Pharmaceuticals
See all newsNASDAQ RESUMED AT 02:24 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:19 PM
Brief: Eloxx Pharmaceuticals Provides ELX-02 And ZKN-013 Program Updates
Brief: Eloxx Pharmaceuticals Confirms That Alport Syndrome Patients Treated With Elx-02 In Phase 2 Study Had Improvement
Brief: Eloxx Pharmaceuticals Inc Reports Results In All Patients Treated With Elx-02 In Phase 2 Clinical Study For Alport Syndrome